(Q50792600)

19 March 2018

title

The role of estrogen and testosterone in female rats in behavioral models of relevance to schizophrenia. (English)

1 reference

19 March 2018

0 references

1 reference

1 reference

1

1 reference

19 March 2018

author name string

Perrin Kwek

series ordinal

2

1 reference

19 March 2018

Maarten van den Buuse

series ordinal

3

1 reference

19 March 2018

publication date

29 July 2011

1 reference

19 March 2018

published in

Psychopharmacology

1 reference

19 March 2018

volume

219

1 reference

19 March 2018

issue

1

1 reference

19 March 2018

page(s)

213-224

1 reference

19 March 2018

Testosterone supports hormone-dependent aggression in female rats

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Serum estradiol concentration required to maintain body weight, attractivity, proceptivity, and receptivity in the ovariectomized female rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

A single administration of testosterone improves visuospatial ability in young women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Ventral striatal noradrenergic mechanisms contribute to sensorimotor gating deficits induced by amphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Testosterone and gonadotropins but not estrogen associated with spatial ability in women suffering from schizophrenia: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Antipsychotic-like properties of 5-alpha-reductase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Gender differences in schizophrenia: hormonal effect or subtypes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

The effect of estrogen on dopamine and serotonin receptor and transporter levels in the brain: an autoradiography study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Sex differences and influence of gonadal hormones on MK801-induced neuronal degeneration in the granular retrosplenial cortex of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Castration reduces the effect of serotonin-1A receptor stimulation on prepulse inhibition in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1A receptor agonist 8-hydroxy-2-dipropylaminotetralin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Use of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) to investigate group and gender differences in schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

The neurobiology of startle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

A randomized trial of the effect of testosterone and estrogen on verbal fluency, verbal memory, and spatial ability in healthy postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Estrogen - a potential treatment for schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Brain serotonin depletion by lesions of the median raphe nucleus enhances the psychotomimetic action of phencyclidine, but not dizocilpine (MK-801), in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Behavioural effects of electrolytic and 6-hydroxydopamine lesions of the accumbens and caudate-putamen nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Female Wistar-Kyoto and SHR/y rats have the same genotype but different patterns of expression of renin and angiotensinogen genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Effects of testosterone and estrogen replacement on memory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

NMDA receptor hypofunction model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Can estradiol modulate schizophrenic symptomatology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Estrogen-serotonin interactions: implications for affective regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Gender and the use of neuroleptics in schizophrenia. Further testing of the oestrogen hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

The role of estrogens in schizophrenia gender differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Testosterone aromatization and cognition in women: a randomized, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Realistic expectations of prepulse inhibition in translational models for schizophrenia research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Effects of estrogen on the basal ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Sensorimotor gating in rats is regulated by different dopamine-glutamate interactions in the nucleus accumbens core and shell subregions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Evaluation of high-dose estrogen and high-dose estrogen plus methyltestosterone treatment on cognitive task performance in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

An integrative neuroanatomical perspective on some subcortical substrates of adaptive responding with emphasis on the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00213-011-2389-Y

21 January 2018

12 December 2020

Effect of prepubertal ovariectomy on amphetamine-induced locomotor activity in adult female rats

1 reference

12 December 2020

Hormonal regulation of rat liver microsomal enzymes. Role of gonadal steroids in programming, maintenance, and suppression of delta 4-steroid 5 alpha-reductase, flavin-containing monooxygenase, and sex-specific cytochromes P-450

1 reference

12 December 2020

Age at onset in subtypes of schizophrenic disorders

1 reference

12 December 2020

Female gonadal hormones, serotonin, and sexual receptivity

1 reference

12 December 2020

Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors

1 reference

12 December 2020

Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients

1 reference

12 December 2020

Dopamine-mediated behaviors: characteristics of modulation by estrogen

1 reference

12 December 2020

Gonadotropin-releasing hormone neurons, NMDA receptors, and their regulation by steroid hormones across the reproductive life cycle

1 reference

12 December 2020

Memory impairment in schizophrenia: a meta-analysis.

1 reference

12 December 2020

10.1007/S00213-011-2389-Y

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018